Approaches to improve photodynamic therapy of cancer.

Photodynamic therapy (PDT) is a clinically approved method of tumor treatment. Its unique mechanism of action results from minimal invasiveness and high selectivity towards transformed cells. However, visible light used to excite most photosensitizers has rather limited ability to penetrate tissues resulting in insufficient destruction of deeply seated malignant cells. Therefore, novel strategies for further potentiation of the anticancer effectiveness of PDT have been developed. These include combined treatments with surgery, chemo- and radiotherapy, strategies targeting cytoprotective mechanisms induced in PDT-treated cells, as well as attempts aimed at enhancement of PDT-mediated antitumor immune response. Moreover, new photosensitizers and novel light sources are being developed. Impressive progress in nanotechnology and understanding of tumor cell biology rise hopes for further improvements in this elegant and promising method of cancer treatment.

[1]  S. Kishi,et al.  Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.

[2]  W. Fong,et al.  Phthalocyanine-polyamine conjugates as pH-controlled photosensitizers for photodynamic therapy. , 2010, Chemistry.

[3]  Qian Peng,et al.  Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin--quantitative studies in normal rat liver. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[4]  R. V. Omkumar,et al.  Bioconjugated quantum dots for cancer research: present status, prospects and remaining issues. , 2010, Biotechnology advances.

[5]  Jiahong Zhou,et al.  A new sol-gel silica nanovehicle preparation for photodynamic therapy in vitro. , 2010, International journal of pharmaceutics.

[6]  J. Usuda,et al.  Management of Multiple Primary Lung Cancer in Patients with Centrally Located Early Cancer Lesions , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  T. Shuin,et al.  Regulation of 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation in Human Urothelial Carcinomas , 2009, Pathobiology.

[8]  T. Hasan,et al.  In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring , 2009, British Journal of Cancer.

[9]  Y. Tsai,et al.  Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  L. Davids,et al.  Melanomas display increased cytoprotection to hypericin‐mediated cytotoxicity through the induction of autophagy , 2009, Cell biology international.

[11]  M. Eljamel,et al.  Photodynamic therapy adjuvant to surgery in metastatic carcinoma in brain. , 2009, Photodiagnosis and photodynamic therapy.

[12]  W. Gallagher,et al.  Porphyrin and Nonporphyrin Photosensitizers in Oncology: Preclinical and Clinical Advances in Photodynamic Therapy , 2009, Photochemistry and photobiology.

[13]  K. Berg,et al.  Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. , 2009, Journal of photochemistry and photobiology. B, Biology.

[14]  I D W Samuel,et al.  An open pilot study of ambulatory photodynamic therapy using a wearable low‐irradiance organic light‐emitting diode light source in the treatment of nonmelanoma skin cancer , 2009, The British journal of dermatology.

[15]  A. Oseroff,et al.  Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy , 2009, Clinical Cancer Research.

[16]  M. Epple,et al.  Calcium phosphate nanoparticles as efficient carriers for photodynamic therapy against cells and bacteria. , 2009, Biomaterials.

[17]  Michael R Hamblin,et al.  Anti-tumor immune response after photodynamic therapy , 2009, World Congress of the International Photodynamic Association.

[18]  Michael R Hamblin,et al.  Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. , 2009, Cancer research.

[19]  Y. Urano,et al.  Design and development of enzymatically activatable photosensitizer based on unique characteristics of thiazole orange. , 2009, Journal of the American Chemical Society.

[20]  Kevin M. Smith,et al.  The binding of analogs of porphyrins and chlorins with elongated side chains to albumin , 2009, European Biophysics Journal.

[21]  F. Berr,et al.  Photophysics and photochemistry of photodynamic therapy: fundamental aspects , 2009, Lasers in Medical Science.

[22]  Xingping Zhou,et al.  Studies on Preparation of Photosensitizer Loaded Magnetic Silica Nanoparticles and Their Anti-Tumor Effects for Targeting Photodynamic Therapy , 2009, Nanoscale research letters.

[23]  Pingping Shen,et al.  Methylene blue‐mediated photodynamic therapy induces mitochondria‐dependent apoptosis in HeLa Cell , 2008, Journal of cellular biochemistry.

[24]  Yong Zhang,et al.  Nanoparticles in photodynamic therapy: an emerging paradigm. , 2008, Advanced drug delivery reviews.

[25]  Aleisha Elliott,et al.  New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host Mouse , 2008, Clinical Cancer Research.

[26]  M. Cook,et al.  Investigation of zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine as an efficient photosensitizer by cyclic voltammetry , 2008 .

[27]  H. Kitchener,et al.  Clinical and Immunologic Results of a Phase II Trial of Sequential Imiquimod and Photodynamic Therapy for Vulval Intraepithelial Neoplasia , 2008, Clinical Cancer Research.

[28]  W. Ahn,et al.  Photodynamic therapy with recombinant adenovirus AdmIL‐12 enhances anti‐tumour therapy efficacy in human papillomavirus 16 (E6/E7) infected tumour model , 2008, Immunology.

[29]  Keith A. Cengel,et al.  Motexafin Lutetium-Photodynamic Therapy of Prostate Cancer: Short- and Long-Term Effects on Prostate-Specific Antigen , 2008, Clinical Cancer Research.

[30]  P. Morlière,et al.  Photophysical properties of a photocytotoxic fluorinated chlorin conjugated to four β-cyclodextrins , 2008, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[31]  Volker Albrecht,et al.  Optimization of treatment parameters for Foscan®‐PDT of basal cell carcinomas , 2008, Lasers in surgery and medicine.

[32]  N. Lange,et al.  Combination of photodynamic therapy with anti-cancer agents. , 2008, Current medicinal chemistry.

[33]  Y. Tamada,et al.  Thioredoxin upregulation by 5‐aminolaevulinic acid‐based photodynamic therapy in human skin squamous cell carcinoma cell line , 2008, Photodermatology, photoimmunology & photomedicine.

[34]  Wei Tang,et al.  Encapsulation of methylene blue in polyacrylamide nanoparticle platforms protects its photodynamic effectiveness. , 2008, Biochemical and biophysical research communications.

[35]  T. Foster,et al.  Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy. , 2008, Journal of biomedical optics.

[36]  Michael R Hamblin,et al.  Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model , 2008, Proceedings of the National Academy of Sciences.

[37]  D. Kessel,et al.  Apoptotic and autophagic responses to Bcl-2 inhibition and photodamage , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[38]  J. Woodhams,et al.  The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[39]  T. Vogl,et al.  A Phase II safety and effect on time to tumor progression study of intratumoral light infusion technology using talaporfin sodium in patients with metastatic colorectal cancer , 2007, Journal of surgical oncology.

[40]  A. Tedesco,et al.  Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. , 2007, Photomedicine and laser surgery.

[41]  Michael R Hamblin,et al.  Photodynamic therapy with fullerenes , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[42]  M. Chopp,et al.  Combination Therapy with Antiangiogenic Treatment and Photodynamic Therapy for the Nude Mouse Bearing U87 Glioblastoma , 2007, Photochemistry and photobiology.

[43]  G. Maira,et al.  m‐THPC‐mediated photodynamic therapy of malignant gliomas: Assessment of a new transfection strategy , 2007, International journal of cancer.

[44]  B. Wilson,et al.  Tetherless fiber-coupled optical sources for extended metronomic photodynamic therapy. , 2007, Photodiagnosis and photodynamic therapy.

[45]  T. Hasan,et al.  Strategies for Enhanced Photodynamic Therapy Effects † , 2007, Photochemistry and photobiology.

[46]  B. Wilson,et al.  Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring. , 2007, Photodiagnosis and photodynamic therapy.

[47]  H. V. Snelling,et al.  Two-photon excitation studies of m-THPC photosensitizer and photodynamic activity in an epithelial cell line. , 2007, Photodiagnosis and photodynamic therapy.

[48]  C. Gomer,et al.  Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response. , 2007, Cancer research.

[49]  Shimon Weiss,et al.  Singlet oxygen production by Peptide-coated quantum dot-photosensitizer conjugates. , 2007, Journal of the American Chemical Society.

[50]  W. Ahn,et al.  Photodynamic therapy‐generated tumor cell lysates with CpG‐oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells , 2007, Cancer science.

[51]  R. Boyle,et al.  Development and characterization of novel photosensitizer :  scFv conjugates for use in photodynamic therapy of cancer , 2007, Immunology.

[52]  Hui Li,et al.  Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. , 2007, Bioconjugate chemistry.

[53]  Paras N Prasad,et al.  Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy. , 2007, Journal of the American Chemical Society.

[54]  K. Berg,et al.  Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. , 2007, Molecular pharmaceutics.

[55]  M. Korbelik,et al.  Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin , 2006, British Journal of Cancer.

[56]  Henricus J C M Sterenborg,et al.  Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. , 2006, The Journal of investigative dermatology.

[57]  S. Kusamura,et al.  Photodynamic therapy using a methyl ester of 5-aminolevulinic acid in recurrent Paget's disease of the vulva: a pilot study. , 2006, Gynecologic oncology.

[58]  David A Russell,et al.  Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse’ , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[59]  Mladen Korbelik,et al.  Photodynamic therapy-generated vaccine for cancer therapy , 2006, Cancer Immunology, Immunotherapy.

[60]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[61]  D. Nowis,et al.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity , 2006, Oncogene.

[62]  T. Dougherty,et al.  Endobronchial photodynamic therapy for lung cancer , 2006, Lasers in surgery and medicine.

[63]  Mladen Korbelik,et al.  PDT‐associated host response and its role in the therapy outcome , 2006, Lasers in surgery and medicine.

[64]  Barbara Owczarczak,et al.  Photodynamic therapy and anti‐tumor immunity , 2006, Lasers in surgery and medicine.

[65]  B. Overholt,et al.  Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high‐grade dysplasia , 2006, Lasers in surgery and medicine.

[66]  D. Kessel,et al.  Initiation of apoptosis and autophagy by photodynamic therapy , 2006, Lasers in surgery and medicine.

[67]  H. Kato,et al.  Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy , 2006, Clinical Cancer Research.

[68]  J. Moan,et al.  Radiosensitization of tumours by porphyrins. , 2006, Cancer letters.

[69]  W. Sibbett,et al.  Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy , 2006, The British journal of dermatology.

[70]  Wei Chen,et al.  Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. , 2006, Journal of nanoscience and nanotechnology.

[71]  Jicun Ren,et al.  Luminescent quantum dots: a very attractive and promising tool in biomedicine. , 2006, Current medicinal chemistry.

[72]  K. Berg,et al.  Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[73]  J. M. Marchetti,et al.  Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. , 2006, International journal of pharmaceutics.

[74]  Michael R Hamblin,et al.  A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy , 2006, British Journal of Cancer.

[75]  M. Novelli,et al.  Photodynamic therapy with WST09 (Tookad): Quantitative studies in normal colon and transplanted tumours , 2006, International journal of cancer.

[76]  H. Matsui,et al.  Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. , 2005, Biochemical pharmacology.

[77]  K. Soo,et al.  Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. , 2005, International journal of molecular medicine.

[78]  E. Eskelinen Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death , 2005, Cell Death and Differentiation.

[79]  M. Tainsky,et al.  A role for manganese superoxide dismutase in apoptosis after photosensitization. , 2005, Biochemical and biophysical research communications.

[80]  M. Mason,et al.  A phase‐1 study of sequential mitomycin C and 5–aminolaevulinic acid‐mediated photodynamic therapy in recurrent superficial bladder carcinoma , 2005, BJU international.

[81]  Oliver J. Clarke,et al.  The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy , 2005, British Journal of Cancer.

[82]  Wei Tang,et al.  Photodynamic Characterization and In Vitro Application of Methylene Blue-containing Nanoparticle Platforms¶ , 2005, Photochemistry and photobiology.

[83]  Mladen Korbelik,et al.  Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.

[84]  Mladen Korbelik,et al.  Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[85]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[86]  P. Mróz,et al.  Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.

[87]  C. Sibata,et al.  Photosensitizers in clinical PDT. , 2004, Photodiagnosis and photodynamic therapy.

[88]  J. Smolle,et al.  Photodynamic therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience. , 2004, Photodiagnosis and photodynamic therapy.

[89]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[90]  Ruomei Gao,et al.  Nanomaterials and singlet oxygen photosensitizers: potential applications in photodynamic therapy , 2004 .

[91]  R. Allman,et al.  Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin‐resistant bladder cancer cell‐line model , 2004, BJU international.

[92]  Xiaobo Chen,et al.  Semiconductor quantum dots for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[93]  W. Greco,et al.  Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. , 2003, Cancer Research.

[94]  P. Mróz,et al.  Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[95]  Indrajit Roy,et al.  Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. , 2003, Journal of the American Chemical Society.

[96]  B W Henderson,et al.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.

[97]  K. Okkenhaug,et al.  Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. , 2003, Cancer research.

[98]  Tayyaba Hasan,et al.  Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. , 2003, Cancer research.

[99]  P. Mróz,et al.  Antitumor Effects of Photodynamic Therapy Are Potentiated by 2-Methoxyestradiol , 2003, The Journal of Biological Chemistry.

[100]  W. Potter,et al.  A Beam‐splitting Device for Use with Fiber‐coupled Laser Light Sources for Photodynamic Therapy ¶ , 2002, Photochemistry and photobiology.

[101]  Zheng Huang,et al.  Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ , 2002, Photochemistry and photobiology.

[102]  Zheng Huang,et al.  Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.

[103]  C. Gomer,et al.  Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.

[104]  A. Rainbow,et al.  Up-regulation of Hsp27 Plays a Role in the Resistance of Human Colon Carcinoma HT29 Cells to Photooxidative Stress¶ , 2002 .

[105]  Rik Roelandts,et al.  The history of phototherapy: something new under the sun? , 2002, Journal of the American Academy of Dermatology.

[106]  P. Mróz,et al.  Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[107]  Kristian Berg,et al.  Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy , 2002, Cancer Gene Therapy.

[108]  Barbara W Henderson,et al.  Generation of effective antitumor vaccines using photodynamic therapy. , 2002, Cancer research.

[109]  B. McManus,et al.  Fas ligand and TRAIL augment the effect of photodynamic therapy on the induction of apoptosis in JURKAT cells. , 2001, International immunopharmacology.

[110]  M. Korbelik,et al.  Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line , 2001, International journal of cancer.

[111]  V. Dima,et al.  New approach to the adoptive immunotherapy of Walker-256 carcinosarcoma with activated macrophages combined with photodynamic therapy. , 2001, Roumanian archives of microbiology and immunology.

[112]  Freya Q. Schafer,et al.  Phospholipid hydroperoxide glutathione peroxidase protects against singlet oxygen-induced cell damage of photodynamic therapy. , 2001, Free radical biology & medicine.

[113]  M. Korbelik,et al.  Interaction Between Photodynamic Therapy and BCG Immunotherapy Responsible for the Reduced Recurrence of Treated Mouse Tumors ¶ , 2001, Photochemistry and photobiology.

[114]  K. Sano,et al.  Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma , 2000, Cancer Immunology, Immunotherapy.

[115]  L. Lilge,et al.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.

[116]  K. Berg,et al.  Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31‐gelonin , 2000, International journal of cancer.

[117]  R. Allman,et al.  Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck , 2000, British Journal of Cancer.

[118]  K. Berg,et al.  Photochemical transfection: a new technology for light-induced, site-directed gene delivery. , 2000, Human gene therapy.

[119]  A. Dabrowska,et al.  Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF , 2000, British Journal of Cancer.

[120]  A. E. Saarnak,et al.  Biodistribution and Bioactivity of Tetra-pegylated Meta-tetra(hydroxyphenyl)chlorin Compared to Native Meta-tetra(hydroxyphenyl)chlorin in a Rat Liver Tumor Model , 2000 .

[121]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[122]  H Anholt,et al.  Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. , 1999, Cancer research.

[123]  M. Obochi,et al.  Photodynamic Alteration of the Surface Receptor Expression Pattern of Murine Splenic Dendritic Cells , 1999, Scandinavian journal of immunology.

[124]  Michael R Hamblin,et al.  Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. , 1998, Cancer research.

[125]  T. Mang,et al.  A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. , 1998, The cancer journal from Scientific American.

[126]  M. Korbelik,et al.  Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. , 1998, Journal of photochemistry and photobiology. B, Biology.

[127]  B. Henderson,et al.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.

[128]  B. Henderson,et al.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.

[129]  J. Krosl,et al.  The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.

[130]  J. Krosl,et al.  Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.

[131]  J. Sessler,et al.  Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.

[132]  Z. Malik,et al.  Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. , 1996, Immunopharmacology.

[133]  C. Gomer,et al.  Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. , 1995, Cancer research.

[134]  Michael R Hamblin,et al.  Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. , 1994, Journal of photochemistry and photobiology. B, Biology.

[135]  M. Korbelik,et al.  Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). , 1994, Cancer letters.

[136]  J. K. Bradley,et al.  Comparing the anti-tumor effect of several bioreductive drugs when used in combination with photodynamic therapy (PDT). , 1994, International journal of radiation oncology, biology, physics.

[137]  J. Kanofsky,et al.  QUENCHING OF SINGLET OXYGEN BY BIOMOLECULES FROM L1210 LEUKEMIA CELLS , 1992, Photochemistry and photobiology.

[138]  B. Wilson,et al.  RESISTANCE TO PHOTODYNAMIC THERAPY IN RADIATION INDUCED FIBROSARCOMA‐1 and CHINESE HAMSTER OVARY‐MULTI‐DRUG RESISTANT CELLS in vitro , 1991, Photochemistry and photobiology.

[139]  C. Gomer,et al.  INCREASED TRANSCRIPTION AND TRANSLATION OF HEME OXYGENASE IN CHINESE HAMSTER FIBROBLASTS FOLLOWING PHOTODYNAMIC STRESS OR PHOTOFRIN II INCUBATION , 1991, Photochemistry and photobiology.

[140]  B. Lau,et al.  Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. , 1989, Urology.

[141]  B W Henderson,et al.  Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice. , 1988, Cancer research.

[142]  Q. Peng,et al.  Photodynamic Therapy , 1988, Methods in Molecular Biology.

[143]  C. Elmets,et al.  In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. , 1988, Biochemical and biophysical research communications.

[144]  B. Henderson,et al.  The influence of cellular glutathione content on cell survival following photodynamic treatment in vitro. , 1986, Radiation research.

[145]  D S Zaharko,et al.  Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light. , 1983, Cancer research.

[146]  Patrizia Agostinis,et al.  Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. , 2010, Biochimica et biophysica acta.

[147]  M. Patterson,et al.  In Vitro Survival of Nonsmall Cell Lung Cancer Cells Following Combined Treatment with Ionizing Radiation and Photofrin‐mediated Photodynamic Therapy , 2009, Photochemistry and photobiology.

[148]  Malini Olivo,et al.  Immune response against angiosarcoma following lower fluence rate clinical photodynamic therapy. , 2008, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[149]  Steffen Jung,et al.  Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity , 2008, Cancer Immunology, Immunotherapy.

[150]  Xiu-yan Wang,et al.  The facile synthesis and characterization of tetraimido-substituted zinc phthalocyanines , 2008 .

[151]  Hong Liu,et al.  Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶ , 2005, Photochemistry and photobiology.

[152]  H. Moseley,et al.  Laser and Non-laser Light Sources for Photodynamic Therapy , 2002, Lasers in Medical Science.

[153]  R. Nordquist,et al.  Antitumor immunity induced by laser immunotherapy and its adoptive transfer. , 2001, Cancer research.

[154]  J. Bhawalkar,et al.  Two-photon photodynamic therapy. , 1997, Journal of clinical laser medicine & surgery.

[155]  B. Steinberg,et al.  Comparative biodistribution of meta‐Tetra (Hydroxyphenyl) chlorin in multiple species: Clinical implications for photodynamic therapy , 1997, Lasers in surgery and medicine.

[156]  D. Bellnier Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha. , 1991, Journal of photochemistry and photobiology. B, Biology.

[157]  D. Bellnier Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α , 1991 .